Foley & Lardner LLP (JD Supra India)
Anti-Bribery Compliance Meets Permits, Approvals and Licences in India
Obtaining permissions, approvals and licences in India creates high risks for bribery on account of there being significant interaction between the company and government authorities. Originally published by IBA Anto-Corruption Committee in October 2017.
Diwali: An Opportune Time for an Anti-Corruption Compliance Reminder
This year, India celebrates Diwali on October 19, 2017. “The Festival of Lights,” as Diwali (or Deepavli) is commonly called, is celebrated across India with great aplomb, joy and, of course, delicious sweets. Diwali signifies the victory of light over darkness and, traditionally, family, friends and business acquaintances will often exchange gifts as part of the festivities. Apart from the...
India Modernizes its Arbitration System: U.S. Companies Should Consider Arbitration Clauses in Indian Commercial Contracts
The Indian court system has gained an unfortunate reputation for being notoriously slow, cumbersome, unpredictable, and unreliable, which makes solving commercial disputes in India a challenging ordeal. India ranks near the bottom in the World Bank’s rankings of contract enforcement; it takes an average of over 1,400 days — more than three years — for a dispute to finally see the light of day,...
India IP Board Invalidates Roche Hepatitis C Patent, Cites KSR
In a decision issued November 2, 2012, the Intellectual Property Appellate Board of India (IPAB) determined in a post-grant opposition proceeding that Roche’s patent covering its Pegasys® (pegylated interferon alfa-2a) product for the treatment of Hepatitis C, is invalid as obvious.